← Leaderboards
Malcolm S. Reid
New York University School Of Medicine
$1,417,867
Attributed
$1,417,867
Total exposure
7
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $389.7K · FY2005–09$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$1,417,867 · 7
By mechanism
R21$645,174 · 2
M01$399,379 · 3
R01$373,314 · 1
N01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Esther P. Gardner$8,317,058
- Josef Coresh$115,254,828
- Bijan Pesaran$14,487,999
- Silvia Saboia Martins$12,198,031
- Lakshmi A Devi$24,104,978
Others in their field
Top investigators on “Cues”
- Jose A Luchsinger · Columbia University Health Sciences$34,510,578
- Elaine Fuchs · University Of Chicago$24,226,767
- Eric A Stach · Purdue University$23,050,000
- Rajita Sinha · Yale University$22,430,223
- Barbara J Mason · Scripps Research Institute, The$21,474,646
- Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute$21,157,888
Research focus
CuesBehavioral /Social Science Research TagHuman SubjectCravingClinical ResearchOutcomes ResearchDrug Addiction AntagonistHuman Therapy EvaluationDrug WithdrawalReinforcerSubstance Abuse Related BehaviorSmoking CessationTobacco AbuseNeurotransmitter AntagonistGlutamatesPatient Oriented ResearchGamma AminobutyrateCocaineGlutamate ReceptorDrug Abuse ChemotherapyChoice BehaviorBehavioralCharacteristicsBioimaging /Biomedical Imaging
Grant awards (12)
Clinical laboratory evaluations of aprepitant for the treatment of opioid depende$373,314
R01 · FY2009 · DA · contact PI
POTENTIAL INTERACTIONS BETWEEN INTRAVENOUS METHAMPHETAMINE AND ARIPIPRAZOLE$150,105
M01 · FY2006 · RR · contact PI
POTENTIAL INTERACTIONS BETWEEN INTRAVENOUS METHAMPHETAMINE AND ARIPIPRAZOLE$210,199
M01 · FY2005 · RR
Glutamatergic Mechanisms in Cigarette Craving and Reward$169,000
R21 · FY2005 · DA
NEURAL CORRELATES OF COCAINE CRAVING AND REWARD$10,456
M01 · FY2005 · RR
MEDICATIONS DEVELOPMENT FOR STIMULANT DEPENDENCE-271038838$0
N01 · FY2005 · DA
Glutamatergic Mechanisms in Cigarette Craving and Reward$169,000
R21 · FY2004 · DA
Neural Correlates of Cocaine Craving and Reward$28,619
M01 · FY2004 · RR
Medications Development for Stimulant Dependence-271038838$0
N01 · FY2004 · DA
Glutamatergic Mechanisms in Cigarette Craving and Reward$166,516
R21 · FY2003 · DA
MEDICATIONS DEVELOPMENT FOR STIMULANT DEPENDENCE-271038838$0
N01 · FY2003 · DA
NEURAL CORRELATES OF COCAINE ADDICTION TREATMENT$140,658
R21 · FY2000 · DA